share_log

据港交所文件:上海百心安生物技术-B通过港交所上市聆讯。

According to Hong Kong Stock Exchange documents, Shanghai Baixinan Biotechnology-B passed the Hong Kong Stock Exchange listing hearing.

新浪財經 ·  Jun 16, 2021 06:44

According to Hong Kong Stock Exchange documents, Shanghai Baixinan Biotechnology-B passed the Hong Kong Stock Exchange listing hearing.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment